|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.2 USD | -2.45% |
|
+4.10% | +6.77% |
| Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
| Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
Dec 6 (Reuters) - The European Medicines Agency said on Tuesday its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults.
The vaccines by Pfizer and BioNTech, as well as rival Moderna are currently authorised only as a booster in the European Union. (Reporting by Sinchita Mitra in Bengaluru)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 106.2 USD | -2.45% | +4.10% | 40.65B | ||
| 86.71 USD | -1.57% | +0.63% | 20.9B | ||
| 25.26 USD | -3.84% | -0.51% | 143B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +6.77% | 40.65B | |
| +1.12% | 42.59B | |
| +47.53% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B | |
| -18.79% | 9.85B |
MODERNA, INC. 
